- Final data from Phase 1b study evaluating subcutaneous infusion of investigational medicine ABBV-951 in patients with advanced Parkinson's disease (PD) to be presented as late breaker - A second ...
Previous studies have shown that, compared with oral levodopa medication, continuous infusion of levodopa–carbidopa (duodopa) gel reduces motor complications in advanced Parkinson disease (PD). A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results